<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37113008</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Identification of a Conserved, Linear Epitope on VP3 of <i>Enterovirus A</i> Species Recognized by a Broad-Spectrum Monoclonal Antibody.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1028</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15041028</ELocationID><Abstract><AbstractText>Outbreaks of hand, foot and mouth disease (HFMD) have occurred frequently in the Asian-Pacific region over the last two decades, caused mainly by the serotypes in <i>Enterovirus A</i> species. High-quality monoclonal antibodies (mAbs) are needed to improve the accuracy and efficiency of the diagnosis of enteroviruses associated HFMD. In this study, a mAb 1A11 was generated using full particles of CV-A5 as an immunogen. In indirect immunofluorescence and Western blotting assays, 1A11 bound to the viral proteins of CV-A2, CV-A4, CV-A5, CV-A6, CV-A10, CV-A16, and EV-A71 of the <i>Enterovirus A</i> and targeted VP3. It has no cross-reactivity to strains of <i>Enterovirus B</i> and <i>C</i>. By mapping with over-lapped and truncated peptides, a minimal and linear epitope <sub>23</sub>PILPGF<sub>28</sub> was identified, located at the N-terminus of the VP3. A BLAST sequence search of the epitope in the NCBI genus <i>Enterovirus</i> (taxid: 12059) protein database indicates that the epitope sequence is highly conserved among the <i>Enterovirus A</i> species, but not among the other enterovirus species, first reported by us. By mutagenesis analysis, critical residues for 1A11 binding were identified for most serotypes of <i>Enterovirus A</i>. It may be useful for the development of a cost-effective and pan-<i>Enterovirus A</i> antigen detection for surveillance, early diagnosis and differentiation of infections caused by the <i>Enterovirus A</i> species.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Lie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao-Yu</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Wei-Ping</ForeName><Initials>WP</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Sha-Sha</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meng-Jun</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wen-Hui</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Sheng-Li</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ze-Jun</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiao-Qi</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0916-053X</Identifier><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus A species</Keyword><Keyword MajorTopicYN="N">broad-spectrum monoclonal antibody</Keyword><Keyword MajorTopicYN="N">linear and conserved epitope</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37113008</ArticleId><ArticleId IdType="pmc">PMC10145497</ArticleId><ArticleId IdType="doi">10.3390/v15041028</ArticleId><ArticleId IdType="pii">v15041028</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meng X.D., Tong Y., Wei Z.N., Wang L., Mai J.Y., Wu Y., Luo Z.Y., Li S., Li M., Wang S., et al. Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China. Sci. Rep. 2020;10:20909. doi: 10.1038/s41598-020-77768-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77768-7</ArticleId><ArticleId IdType="pmc">PMC7708472</ArticleId><ArticleId IdType="pubmed">33262488</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Ren M., Chen S., Nie T., Cui J., Ran L., Li Z., Chang Z. Pathogen spectrum of hand, foot, and mouth disease based on laboratory surveillance—China, 2018. China CDC Wkly. 2020;2:167–171. doi: 10.46234/ccdcw2020.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2020.044</ArticleId><ArticleId IdType="pmc">PMC8393163</ArticleId><ArticleId IdType="pubmed">34594617</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X., Wan Z., Li Y., Hu Y., Jin X., Zhang C. National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol. Sin. 2020;35:21–33. doi: 10.1007/s12250-019-00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00169-2</ArticleId><ArticleId IdType="pmc">PMC7035399</ArticleId><ArticleId IdType="pubmed">31664644</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Chen T., Peng J., Luo Y., Du L., Lu Z., He J., Liu C., Gan Q., Ma W., et al. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV-A71 vaccination in Kunming, China, 2017–2020. Sci. Rep. 2022;12:17028. doi: 10.1038/s41598-022-21312-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-21312-2</ArticleId><ArticleId IdType="pmc">PMC9552732</ArticleId><ArticleId IdType="pubmed">36220850</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikonov O.S., Chernykh E.S., Garber M.B., Nikonova E.Y. Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs. Biochemistry. 2017;82:1615–1631. doi: 10.1134/S0006297917130041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297917130041</ArticleId><ArticleId IdType="pmc">PMC7087576</ArticleId><ArticleId IdType="pubmed">29523062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo C.W., Wu K.G., Lin M.C., Chen C.J., Ho D.M., Tang R.B., Chan Y.J. Application of a molecular method for the classification of human enteroviruses and its correlation with clinical manifestations. J. Microbiol. Immunol. Infect. 2010;43:354–359. doi: 10.1016/S1684-1182(10)60056-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1684-1182(10)60056-4</ArticleId><ArticleId IdType="pubmed">21075700</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams M.J., Lefkowitz E.J., King A.M., Bamford D.H., Breitbart M., Davison A.J., Ghabrial S.A., Gorbalenya A.E., Knowles N.J., Krell P., et al. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2015) Arch. Virol. 2015;160:1837–1850. doi: 10.1007/s00705-015-2425-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-015-2425-z</ArticleId><ArticleId IdType="pubmed">25913692</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams M.J., Lefkowitz E.J., King A.M., Harrach B., Harrison R.L., Knowles N.J., Kropinski A.M., Krupovic M., Kuhn J.H., Mushegian A.R., et al. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2016) Arch. Virol. 2016;161:2921–2949. doi: 10.1007/s00705-016-2977-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-2977-6</ArticleId><ArticleId IdType="pmc">PMC7086986</ArticleId><ArticleId IdType="pubmed">27424026</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker P.J., Siddell S.G., Lefkowitz E.J., Mushegian A.R., Adriaenssens E.M., Alfenas-Zerbini P., Dempsey D.M., Dutilh B.E., García M.L., Curtis Hendrickson R., et al. Recent changes to virus taxonomy ratified by the International Committee on Taxonomy of Viruses (2022) Arch. Virol. 2022;167:2429–2440. doi: 10.1007/s00705-022-05516-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-022-05516-5</ArticleId><ArticleId IdType="pmc">PMC10088433</ArticleId><ArticleId IdType="pubmed">35999326</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer L., Moreni G., Wolthers K.C., Pajkrt D. World-wide prevalence and genotype distribution of enteroviruses. Viruses. 2021;13:434. doi: 10.3390/v13030434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030434</ArticleId><ArticleId IdType="pmc">PMC7999254</ArticleId><ArticleId IdType="pubmed">33800518</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah P.N.M., Filman D.J., Karunatilaka K.S., Hesketh E.L., Groppelli E., Strauss M., Hogle J.M. Cryo-EM structures reveal two distinct conformational states in a picornavirus cell entry intermediate. PLoS Pathog. 2020;16:e1008920. doi: 10.1371/journal.ppat.1008920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008920</ArticleId><ArticleId IdType="pmc">PMC7549760</ArticleId><ArticleId IdType="pubmed">32997730</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., Sun Y., Fan J., Zhu B., Cao L., Gao Q., Zhang Y., Liu H., Rao Z., Wang X. Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating. Nat. Commun. 2018;9:4985. doi: 10.1038/s41467-018-07531-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07531-0</ArticleId><ArticleId IdType="pmc">PMC6255764</ArticleId><ArticleId IdType="pubmed">30478256</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir P., Kämmerer U., Korn K., Mulders M.N., Pöyry T., Weissbrich B., Kandolf R., Cleator G.M., van Loon A.M. Molecular typing of enteroviruses: Current status and future requirements. The european union concerted action on virus meningitis and encephalitis. Clin. Microbiol. Rev. 1998;11:202–227. doi: 10.1128/CMR.11.1.202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.11.1.202</ArticleId><ArticleId IdType="pmc">PMC121380</ArticleId><ArticleId IdType="pubmed">9457433</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura N., Semler B.L., Rothberg P.G., Larsen G.R., Adler C.J., Dorner A.J., Emini E.A., Hanecak R., Lee J.J., van der Werf S., et al. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981;291:547–553. doi: 10.1038/291547a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/291547a0</ArticleId><ArticleId IdType="pubmed">6264310</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor P.D. The molecular biology of poliovaccines. J. Gen. Virol. 1992;73:3065–3077. doi: 10.1099/0022-1317-73-12-3065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-73-12-3065</ArticleId><ArticleId IdType="pubmed">1335021</ArticleId></ArticleIdList></Reference><Reference><Citation>Francisco-Velilla R., Embarc-Buh A., Abellan S., Martinez-Salas E. Picornavirus translation strategies. FEBS Openbio. 2022;12:1125–1141. doi: 10.1002/2211-5463.13400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.13400</ArticleId><ArticleId IdType="pmc">PMC9157412</ArticleId><ArticleId IdType="pubmed">35313388</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu M.G. Antibody recognition of picornaviruses and escape from neutralization: A structural view. Virus Res. 1995;38:1–24. doi: 10.1016/0168-1702(95)00048-U.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00048-U</ArticleId><ArticleId IdType="pubmed">8546007</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor P.D., Ferguson M., Evans D.M., Almond J.W., Icenogle J.P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J. Gen. Virol. 1986;67:1283–1291. doi: 10.1099/0022-1317-67-7-1283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-67-7-1283</ArticleId><ArticleId IdType="pubmed">2425046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Zhang Y., Li H., Liu L. Hand-Foot-and-Mouth Disease-associated enterovirus and the development of multivalent HFMD Vaccines. Int. J. Mol. Sci. 2022;24:169. doi: 10.3390/ijms24010169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24010169</ArticleId><ArticleId IdType="pmc">PMC9820767</ArticleId><ArticleId IdType="pubmed">36613612</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Principi N. Hand, foot and mouth disease: Current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur. J. Clin. Microbiol. Infect. Dis. 2018;37:391–398. doi: 10.1007/s10096-018-3206-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-018-3206-x</ArticleId><ArticleId IdType="pubmed">29411190</ArticleId></ArticleIdList></Reference><Reference><Citation>Légeret C., Furlano R. Oral ulcers in children- a clinical narrative overview. Ital. J. Pediatr. 2021;47:144. doi: 10.1186/s13052-021-01097-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01097-2</ArticleId><ArticleId IdType="pmc">PMC8246667</ArticleId><ArticleId IdType="pubmed">34193212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassef C., Ziemer C., Morrell D.S. Hand-foot-and-mouth disease: A new look at a classic viral rash. Curr. Opin. Pediatr. 2015;27:486–4891. doi: 10.1097/MOP.0000000000000246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000000246</ArticleId><ArticleId IdType="pubmed">26087425</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E.J., Shin Y.J., Kim J.H., Kim T.G., Chang S.Y. Enterovirus 71 infection and vaccines. Clin. Exp. Vaccine Res. 2017;6:4–14. doi: 10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuorinen T., Vainionpää R., Hyypiä T. Five years’ experience of reverse-transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections. Clin. Infect. Dis. 2003;37:452–455. doi: 10.1086/376635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/376635</ArticleId><ArticleId IdType="pubmed">12884172</ArticleId></ArticleIdList></Reference><Reference><Citation>Aw-Yong K.L., Tan C.W., Koh M.T., Sam I.C., Chan Y.F. Diagnosis of human enterovirus A71 infection in Malaysia using a commercial IgM-capture enzyme-linked immunosorbent assay and an IgM-colloidal gold immunochromatographic assay. Trop. Biomed. 2016;33:238–245.</Citation><ArticleIdList><ArticleId IdType="pubmed">33579090</ArticleId></ArticleIdList></Reference><Reference><Citation>Andréoletti L., Blassel-Damman N., Dewilde A., Vallée L., Cremer R., Hober D., Wattré P. Comparison of use of cerebrospinal fluid, serum, and throat swab specimens in diagnosis of enteroviral acute neurological infection by a rapid RNA detection PCR assay. J. Clin. Microbiol. 1998;36:589–591. doi: 10.1128/JCM.36.2.589-591.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.36.2.589-591.1998</ArticleId><ArticleId IdType="pmc">PMC104586</ArticleId><ArticleId IdType="pubmed">9466785</ArticleId></ArticleIdList></Reference><Reference><Citation>Rittichier K.R., Bryan P.A., Bassett K.E., Taggart E.W., Enriquez F.R., Hillyard D.R., Byington C.L. Diagnosis and outcomes of enterovirus infections in young infants. Pediatr. Infect. Dis. J. 2005;24:546–550. doi: 10.1097/01.inf.0000164810.60080.ad.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000164810.60080.ad</ArticleId><ArticleId IdType="pubmed">15933567</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerly S., Gervaix A., Simonet V., Caflisch M., Perrin L., Wunderli W. Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitis. J. Clin. Microbiol. 1996;34:199–201. doi: 10.1128/jcm.34.1.199-201.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.34.1.199-201.1996</ArticleId><ArticleId IdType="pmc">PMC228761</ArticleId><ArticleId IdType="pubmed">8748304</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanh T.T., Anh N.T., Tham N.T., Van H.M., Sabanathan S., Qui P.T., Ngan T.T., Van T.T., Nguyet L.A., Ny N.T., et al. Validation and utilization of an internally controlled multiplex Real-time RT-PCR assay for simultaneous detection of enteroviruses and enterovirus A71 associated with hand foot and mouth disease. Virol. J. 2015;12:85. doi: 10.1186/s12985-015-0316-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0316-2</ArticleId><ArticleId IdType="pmc">PMC4464700</ArticleId><ArticleId IdType="pubmed">26050791</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C., Cordey S., Van Belle S., Turin L., Lee W.M., Regamey N., Meylan P., Mühlemann K., Gobbini F., Kaiser L. New molecular detection tools adapted to emerging rhinoviruses and enteroviruses. J. Clin. Microbiol. 2009;47:1742–1749. doi: 10.1128/JCM.02339-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02339-08</ArticleId><ArticleId IdType="pmc">PMC2691104</ArticleId><ArticleId IdType="pubmed">19339471</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A., Forsgren M., Sällberg M. Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody. Clin. Diagn. Lab. Immunol. 1995;2:385–386. doi: 10.1128/cdli.2.3.385-386.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cdli.2.3.385-386.1995</ArticleId><ArticleId IdType="pmc">PMC170165</ArticleId><ArticleId IdType="pubmed">7545081</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef G.E., Mann G.F., Brown I.N., Mowbray J.F. Clinical and research application of an enterovirus group-reactive monoclonal antibody. Intervirology. 1987;28:199–205. doi: 10.1159/000150017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000150017</ArticleId><ArticleId IdType="pubmed">2835329</ArticleId></ArticleIdList></Reference><Reference><Citation>Man-Li T., Szyporta M., Fang L.X., Kwang J. Identification and characterization of a monoclonal antibody recognizing the linear epitope RVADVI on VP1 protein of enterovirus 71. J. Med. Virol. 2012;84:1620–1627. doi: 10.1002/jmv.23372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23372</ArticleId><ArticleId IdType="pubmed">22930511</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Huang X., Liu Q., Huang Z. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16. Vaccine. 2013;31:2130–2136. doi: 10.1016/j.vaccine.2013.02.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.02.051</ArticleId><ArticleId IdType="pubmed">23499595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z., Ye X., Shi J., Wang X., Liu Q., Huang Z. Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J. Virol. 2015;89:12084–12095. doi: 10.1128/JVI.02189-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02189-15</ArticleId><ArticleId IdType="pmc">PMC4645313</ArticleId><ArticleId IdType="pubmed">26401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim X.F., Jia Q., Khong W.X., Yan B., Premanand B., Alonso S., Chow V.T., Kwang J. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS ONE. 2012;7:e29751. doi: 10.1371/journal.pone.0029751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029751</ArticleId><ArticleId IdType="pmc">PMC3261156</ArticleId><ArticleId IdType="pubmed">22279543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener T.K., Jia Q., Lim X.F., He F., Meng T., Chow V.T., Kwang J. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol. J. 2012;9:55. doi: 10.1186/1743-422X-9-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-55</ArticleId><ArticleId IdType="pmc">PMC3307493</ArticleId><ArticleId IdType="pubmed">22361222</ArticleId></ArticleIdList></Reference><Reference><Citation>Standardization Administration of China  Laboratory Animal-Guideline for Ethical Review of Animal Welfare. Standardization Administration of China.  [(accessed on 13 September 2022)];2018  Available online:  https://openstd.samr.gov.cn/bzgk/gb/newGbInfo?hcno=9BA619057D5C13103622A10FF4BA5D14.</Citation></Reference><Reference><Citation>Jin W.P., Lu J., Zhang X.Y., Wu J., Wei Z.N., Mai J.Y., Qian S.S., Yu Y.T., Meng S.L., Wang Z.J., et al. Efficacy of coxsackievirus A5 vaccine candidates in an actively immunized mouse model. J. Virol. 2021;95:e01743-20. doi: 10.1128/JVI.01743-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01743-20</ArticleId><ArticleId IdType="pmc">PMC8094937</ArticleId><ArticleId IdType="pubmed">33408178</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y.X., Jin W.P., Wei Z.N., Lv S.Y., Wang M.J., Meng S.L., Guo J., Wang Z.J., Shen S. Identification of specific and shared epitopes at the extreme N-terminal VP1 of Coxsackievirus A4, A2 and A5 by monoclonal antibodies. Virus Res. 2023;328:199074. doi: 10.1016/j.virusres.2023.199074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2023.199074</ArticleId><ArticleId IdType="pmc">PMC10194160</ArticleId><ArticleId IdType="pubmed">36805409</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef G.E., Brownm I.N., Mowbray J.F. Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology. 1987;28:163–170. doi: 10.1159/000150012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000150012</ArticleId><ArticleId IdType="pubmed">2836335</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarinen N.V.V., Laiho J.E., Richardson S.J., Zeissler M., Stone V.M., Marjomäki V., Kantoluoto T., Horwitz M.S., Sioofy-Khojine A., Honkimaa A., et al. A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses. Sci. Rep. 2018;8:33. doi: 10.1038/s41598-017-18495-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18495-4</ArticleId><ArticleId IdType="pmc">PMC5758616</ArticleId><ArticleId IdType="pubmed">29311608</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao L.Y., Pierce C., Gray-Johnson J., DeLotell J., Shaw C., Chapman N., Yeh E., Schnurr D., Huang Y.T. Monoclonal antibodies to VP1 recognize a broad range of enteroviruses. J. Clin. Microbiol. 2009;47:3108–3113. doi: 10.1128/JCM.00479-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00479-09</ArticleId><ArticleId IdType="pmc">PMC2756915</ArticleId><ArticleId IdType="pubmed">19710278</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.Y., Jin W.P., Wang W.H., Wu J., Lu J., Meng S.L., Wang Z.J., Shen S. Generation of anti-CV-A5 polyclonal and monoclonal antibodies and establishment of quantitative antigen ELISA. Chin. J. Immunol. 2021;37:1346–1351. (In Chinese)</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>